Official health agencies including the CDC and WHO assess global risk from the limited May 2026 Andes virus outbreak on the MV Hondius cruise ship as low, with roughly 10 confirmed cases and three deaths contained among passengers and crew. Andes virus, the only hantavirus known for person-to-person spread, caused hantavirus pulmonary syndrome in this cluster, yet sequencing shows no evidence of enhanced transmissibility or sustained community chains beyond close contact. Routine U.S. surveillance reports fewer than 900 total cases since 1993, underscoring the virus's typical rodent-borne, low-human-spread pattern. Trader consensus at 96% "No" reflects these containment data and expert views that efficient airborne or sustained transmission would require substantial evolutionary changes unlikely by year-end. Ongoing monitoring through case reporting and genomic sequencing provides the main near-term variables that could alter odds if unexpected spread emerges.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedHantavirus pandemic in 2026?
Hantavirus pandemic in 2026?
$15,355,112 Vol.
$15,355,112 Vol.
Dec 31, 2026
$15,355,112 Vol.
$15,355,112 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.Official health agencies including the CDC and WHO assess global risk from the limited May 2026 Andes virus outbreak on the MV Hondius cruise ship as low, with roughly 10 confirmed cases and three deaths contained among passengers and crew. Andes virus, the only hantavirus known for person-to-person spread, caused hantavirus pulmonary syndrome in this cluster, yet sequencing shows no evidence of enhanced transmissibility or sustained community chains beyond close contact. Routine U.S. surveillance reports fewer than 900 total cases since 1993, underscoring the virus's typical rodent-borne, low-human-spread pattern. Trader consensus at 96% "No" reflects these containment data and expert views that efficient airborne or sustained transmission would require substantial evolutionary changes unlikely by year-end. Ongoing monitoring through case reporting and genomic sequencing provides the main near-term variables that could alter odds if unexpected spread emerges.
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Market Opened: May 4, 2026, 10:26 AM ET
Volume
$15,355,112End Date
Dec 31, 2026Market Opened
May 4, 2026, 10:26 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.Official health agencies including the CDC and WHO assess global risk from the limited May 2026 Andes virus outbreak on the MV Hondius cruise ship as low, with roughly 10 confirmed cases and three deaths contained among passengers and crew. Andes virus, the only hantavirus known for person-to-person spread, caused hantavirus pulmonary syndrome in this cluster, yet sequencing shows no evidence of enhanced transmissibility or sustained community chains beyond close contact. Routine U.S. surveillance reports fewer than 900 total cases since 1993, underscoring the virus's typical rodent-borne, low-human-spread pattern. Trader consensus at 96% "No" reflects these containment data and expert views that efficient airborne or sustained transmission would require substantial evolutionary changes unlikely by year-end. Ongoing monitoring through case reporting and genomic sequencing provides the main near-term variables that could alter odds if unexpected spread emerges.
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Volume
$15,378,772End Date
Dec 31, 2026Market Opened
May 4, 2026, 10:26 AM ETResolver
0x65070BE91...Official health agencies including the CDC and WHO assess global risk from the limited May 2026 Andes virus outbreak on the MV Hondius cruise ship as low, with roughly 10 confirmed cases and three deaths contained among passengers and crew. Andes virus, the only hantavirus known for person-to-person spread, caused hantavirus pulmonary syndrome in this cluster, yet sequencing shows no evidence of enhanced transmissibility or sustained community chains beyond close contact. Routine U.S. surveillance reports fewer than 900 total cases since 1993, underscoring the virus's typical rodent-borne, low-human-spread pattern. Trader consensus at 96% "No" reflects these containment data and expert views that efficient airborne or sustained transmission would require substantial evolutionary changes unlikely by year-end. Ongoing monitoring through case reporting and genomic sequencing provides the main near-term variables that could alter odds if unexpected spread emerges.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions